AbbVie raises 2027 sales forecast for new immunology drugs to $27 billion
Global Banking & Finance
FEBRUARY 2, 2024
AbbVie raises 2027 sales forecast for new immunology drugs to $27 billion By Leroy Leo and Patrick Wingrove (Reuters) -AbbVie on Friday raised its 2027 forecast for sales of its immunology drugs Skyrizi and Rinvoq to $27 billion, up $6 billion from its previous prediction.
Let's personalize your content